The Earth Times Online Newspaper (Free subscription) | yesterday
LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif. - GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S. Food and Drug Administration (FDA) has extended the original Prescription Drug User Fee Act (PDUFA) goal date for its review of th
Business Wire (Free subscription) | yesterday
LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif.--(BUSINESS WIRE)--GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S. Food and Drug Administration (FDA) has extended the original Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application (NDA) for GSK1838262/XP13512 (gabapentin enacarbil) to February 9, 2010....
Hogs Haven (Free subscription) | 06/11/2009
Tomorrow, at FedEx Field, between 12 noon and 2 pm EST, the Washington Redskins and Joe Theismann are working with GlaxoSmithKline to call a Time Out for Veterans' Health for the second year and counting to help increase awareness about the prevalence of chronic diseases. Through this health screening event, along with other childhood obesity prevention and health awareness programming, GlaxoSmithKline...
Medical News Today (Free subscription) | 06/11/2009
Antigenics, Inc. (NASDAQ: AGEN) today indicated that GlaxoSmithKline's (GSK) Phase III malaria vaccine clinical trial, containing Antigenics' QS-21 Stimulon® adjuvant, has enrolled more than 5,000 children to date and is expected to involve up to 16,000 children. The pivotal efficacy study of RTS,S, the world's most clinically advanced malaria vaccine, is ongoing in seven African countries.
Daily News Analysis (Free subscription) | yesterday
British drugmaker GlaxoSmithKline is currently Saudi Arabia's sole supplier of a vaccine for the H1N1 flu virus.
Jay Currie (Free subscription) | 05/11/2009
The federal government put in an order for 50 million doses of swine flu vaccine — enough to vaccinate everyone in the country 1.5 times — with GlaxoSmithKline in early August. As of this week, GSK has delivered to the feds, and the feds have shipped to the provinces, 6.7 million doses. But at last [...]
Online Clinic News (Free subscription) | 05/11/2009
Two of the biggest pharmaceutical firms this week took the unusual move of pooling their HIV treatments. The new group has been named Viiv Healthcare and was formed by Pfizer and GlaxoSmithKline. Viiv will take over GSK’s collection of HIV medicines, which are becoming slightly outdated (one otf their biggest sellers Combivir is due to lose its patent in 3 years) and Pzifer’s new and largely...
SeekingAlpha.com (Free subscription) | 05/11/2009
Zacks.com submits: Human Genome Sciences, Inc. ( HGSI ) reported third quarter net loss of $49 million or 32 cents per share, in-line with the Zacks Consensus Estimate. The company reported a net loss of $74.2 million or 50 cents in the year ago quarter. The lower net loss for the quarter was primarily attributable to increased revenues from manufacturing and development services and lower operating...
Fiercebiotech (Free subscription) | 05/11/2009
Look for a spike in outsourcing at Genmab. The Danish antibody developer says it is reorganizing the company and turning to vendors to do more clinical development work after it axes 300 staff jobs and sells its U.S. manufacturing business. "The workload for Genmab's development employees, in particular, has decreased and is expected to remain low as partners take on increasing responsibility...
ITSinsider (Free subscription) | 05/11/2009
Enterprise 2.0 is a Crock!!! says Dennis (the 2.0 Menace). Here’s who says it isn’t: Accenture+ Adidas Group+ Alcatel-Lucent+ Alcoa+ Allstate+ Alstom Power+ AMD+ AT&T+ Bell Canada+ Booz Allen Hamilton+ British Petroleum+ CapitalOne+ Cardiff University (UK)+ Chubb+ Cisco+ Compagnie de Saint Gobain+ Compuware+ Corning+ Covidien+ CSC+ Deloitte+ Deutsche Bank+ The Disney Corporation+ DuPont+...
In the Pipeline (Free subscription) | 05/11/2009
Resveratrol's a mighty interesting compound. It seems to extend lifespan in yeast and various lower organisms, and has a wide range of effects in mice. Famously, GlaxoSmithKline has expensively bought out Sirtris, a company whose entire research program started with resveratrol and similar compound that modulate the SIRT1 pathway. But does it really do that? The picture just got even more complicated....
SeekingAlpha ETFs (Free subscription) | 05/11/2009
Mike Havrilla submits: Investors who are bullish on the generic drug industry may consider implementing a 130 / 30 global pharma investing strategy through equal-weight (5% each) short positions for the six brand drug companies outlined below with 30% of their assets while investing 130% of assets in long positions among generic drug makers. The list of brand drug companies with significant patent...
Buckdog (Free subscription) | 04/11/2009
A lot of Canadians would like to get a shot of H1N1 vaccine, but the Federal Government has screwed things up so badly that frustrations continue to rise across the nation: Extra Canadian flu vaccine sent abroad " Extra vaccine for the H1N1 virus has been exported out of Canada to other countries because producers are making more vaccine than can be stored in bottles, officials say. Canada's chief...
Madison County Record (Free subscription) | 04/11/2009
Mendelsohn Retiring Madison County Associate Judge Ralph Mendelsohn won't be kicking back and relaxing after he leaves the bench in December. Mendelsohn, 66, is already searching for work in private practice. Mendelsohn's Dec. 21 retirement was announced last month by Chief Judge Ann Callis' office. Mendelsohn said in an interview with the Madison County Record Tuesday that he was retiring before...
bizjournals (Free subscription) | 04/11/2009
Synta Pharmaceuticals Corp. booked a profit and revenue increase in the most-recent quarter due to the accelerated receipt of payments from a partnership with GlaxoSmithKline.
Videos